This $2,000,000 federal Project Grant award from the National Institutes of Health (NIH) Office of Research Infrastructure Programs (ORIP) under CFDA 93.351 supports the replacement of a 14T high-field vertical-bore nuclear magnetic resonance (NMR) spectrometer and microimager at Massachusetts General Hospital (MGH). The specialized MR imaging and spectroscopy equipment has been a key research resource enabling biomedical investigations across diverse fields, including cancer, neuroscience,...
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), provides $185,625 to The General Hospital Corporation (doing business as Massachusetts General Hospital) to develop a novel magnetic resonance imaging (MRI) technology. The technology aims to address the flip angle inhomogeneity problem in high-field 7 Tesla MRI through the...
This Project Grant award from the National Institute of Mental Health (CFDA 93.242 - Mental Health Research Grants) will provide $600,000 to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to purchase a next-generation 3 Tesla human MRI scanner for mental health research. The new MRI system will replace an obsolete 16-year-old scanner and integrate with MGH's existing PET-MRI facility at the Athinoula A. Martinos Center for Biomedical Imaging. The...
This Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Research Infrastructure Programs (CFDA 93.351) provides $872,734 to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to acquire a Leica Stellaris 8 Falcon confocal microscope. The new microscope will modernize the imaging platform at MGH's Center for Immunology and Inflammatory Diseases (CIID), replacing an aging confocal microscope that is no longer...
The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), was awarded a $161,169 Project Grant by the Office of the Director at the National Institutes of Health under the Research Infrastructure Programs (CFDA 93.351) to purchase a state-of-the-art metabolic/gas exchange system compatible with magnetic resonance imaging (MRI). This specialized equipment will enable a wide range of breath-by-breath gas exchange and pulmonary function measurements as well as...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $1,758,475 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to develop next-generation in-vivo diffusion MRI (DMRI) technologies. The project aims to overcome key challenges with current DMRI methods, including lack of sensitivity to detect...
This $2,000,000 Project Grant award from the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351) will fund the purchase of a new 3T Siemens Vida MRI system for the Pennington Biomedical Research Center (PBRC) in Louisiana. The state-of-the-art MRI system will replace two aging GE 3T scanners and significantly increase PBRC's capacity to perform human metabolism-related research scans, including studies on obesity, diabetes, cancer, aging, and...
The federal Project Grant award S10OD038204 was provided by the National Institutes of Health (NIH) Office of Research Infrastructure Programs (ORIP), under the CFDA program 93.351 - Research Infrastructure Programs. The $578,070 award will fund the purchase of a high-resolution portable photon counting computed tomography (CT) scanner, the OmniTom Elite, to be shared by researchers at Massachusetts General Hospital (MGH) and Boston Children's Hospital. This specialized CT scanner will expand...
The federal Project Grant award R01EB036561, totaling $514,357, was provided by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The grant supports the development of a portable, liquid-helium-free 1-T/560-mm RT bore point-of-care MRI magnet prototype. This innovative medical imaging technology is aimed at transforming the diagnosis and treatment of...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $1,360,447.52 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to develop and evaluate an inexpensive, lightweight "brain monitor" device using magnetic resonance imaging (MRI) technology. The goal is to create a portable MRI-based...
This $1,835,840 Project Grant awarded by the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351) will fund the purchase of a clinical-grade NVision Polaris C13 Polarizer at Massachusetts General Hospital (MGH). The polarizer will enable hyperpolarized C13 MRI, providing over 10,000-fold increases in MRI signal for real-time tracking of metabolic pathways. This technology has shown promise in over 30 clinical trials for cancer imaging and has potential applications in neurodegenerative and liver disorders. As the only site in New England with this capability, the polarizer will allow MGH to translate extensive preclinical research into the clinical realm and collaborate with researchers across the Boston area. The award will support the integration of this C13 polarizer with MGH's existing PET/MR system, enabling combined C13 MRI-PET imaging. The project period runs from August 2025 to July 2026.